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Abstract 
 
Background: The appropriate expression of specific neurotransmitter receptors 
within the cellular networks which compose the enteric nervous system (ENS) is 
central to the regulation of gastrointestinal (GI) functions. Whilst the ENS expression 
patterns of the neurotransmitter glutamate have been well documented, the 
localisation of its receptors on ENS neurons remains to be fully characterised. We 
investigated the expression patterns of glutamate receptor AMPA subunits within 
ENS neurons of the mouse colon and the consequences of their pharmacological 
activation on spontaneous colonic contractility.  
Methods: RT-PCR was used to detect individual AMPA receptor (GluR 1-4) subunit 
expression at the mRNA level in mouse colon tissue. Immunohistochemistry and 
confocal microscopy was used to localise the expression of the GluR1, 4 subunits in 
colon tissue. Brain tissue was used as a positive control. Organ bath preparations 
were used to determine the effect of AMPA receptors activation on the force and 
frequency of colonic longitudinal smooth muscle spontaneous contractions. 
Key Results: GluR1, 3, 4 mRNA was detected in the mouse colon. Immunoreactivity 
for GluR1 and 4 subunits was detected on the somatic and dendritic surfaces of sub-
populations of neurochemically defined ENS neurons. The pharmacological 
activation of AMPA receptors increased the force but not frequency of spontaneous 
colonic contractions.     
Conclusions & Inferences: Molecularly distinct AMPA receptor subtypes are 
differentially expressed within the neural networks of the mouse colon and have a 
direct role in motility. These data provide the rationale for the development of AMPA-
selective ligands for the therapeutic delivery to the GIT in motility disorders.  
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Key Messages 
 
 The excitatory neurotransmitter glutamate is widely expressed within the cellular 
networks of the mammalian enteric nervous system (ENS), yet the expression 
and function of its receptor subtypes is poorly defined.   
 We investigated the expression of AMPA receptor subunits (GluR1-4) within the 
mouse colon and the effect of their pharmacological activation on spontaneous 
colonic contractions. 
 RT-PCR analyses demonstrated that the GluR1, 3, 4 subunits were expressed in 
the colon at the mRNA levels, immunohistochemistry and confocal microscopy 
revealed that the GluR1 and 4 subunits are expressed on neurochemically-
defined ENS neurons and organ bath studies indicated that the pan-AMPA 
receptor activation increased the force but not frequency of spontaneous colonic 
contractions. 
 The data suggest a central role for AMPA receptors in ENS neuronal excitability 
as well as glutamate-mediated GI contractility. 
 
.  
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Introduction  
 
The enteric nervous system (ENS) is principally occupied with the regulation of 
gastrointestinal (GI) function (1). Located within the muscle layers of the GI tract 
(GIT),  the ENS provides the local neural control of virtually all GI functions such as 
peristalsis (2), secretion (3), barrier function (4, 5) and local immune function (1, 6, 
7), whilst cooperating with CNS reflex and command centres to control digestive 
functions (8). These diverse, ENS-mediated GI functions are brought about by the 
exquisite communication between a diverse array of ENS neuronal networks and GI 
cellular components, allowing for GI homeostasis. The importance of ENS function to 
GI health is underscored by the plethora of debilitating GI disorders associated with 
ENS dysfunction such as irritable bowel syndrome (IBS) and inflammatory bowel 
diseases (IBD) (9). Therefore, understanding the vast repertoire of cells and 
molecules which underpin coordinated activity between the cellular elements of the 
ENS and the GIT is central to designing targeted therapies for such disorders 
implicating ENS dysfunction.  
 
The ENS is composed of morphologically, molecularly and functionally distinct cell-
types (10) which communicate using multiple neurotransmitter-receptor systems (11), 
including glutamate (12). Glutamate is the major excitatory neurotransmitter within 
the nervous system (CNS) (13, 14). Its importance to overall neural function is 
exemplified within the CNS, where dysregulation in various glutamatergic pathways 
within the brain has been directly implicated in a number of neurological disorders 
such as epilepsy (15), amnesia (16), schizophrenia (17) and cerebral ischemia (18). 
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Within the ENS, glutamate has been shown to be expressed by different enteric 
neurons and to act as a neurotransmitter (12, 19).  
 
Glutamatergic neurotransmission occurs in a variety of functional phenotypes due to 
the structurally and functionally diverse classes of glutamatergic receptors expressed 
within cellular networks (20). Slow, persistent excitatory glutamatergic currents are 
mediated primarily by different classes of metabotropic glutamate receptors (21). In 
contrast, rapid excitatory glutamatergic currents are mediated primarily by ionotropic 
glutamate receptors which include the N-methyl-D-aspartate receptor (NMDA), 
Kainite and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) sub-
classes (12, 22). Ionotropic glutamate receptor complexes are integral membrane ion 
channels, composed of four subunit proteins which assemble to form a central ion 
channel pore permeable to cations (20). The biophysical and pharmacological 
diversity of different ionotropic glutamate receptors arises from the molecular 
diversity of the subunits forming the receptor complex (20). Therefore, to fully 
understand the role of the glutamate receptor system within specific neural pathways, 
it is essential to determine which particular glutamate receptor subunits are 
expressed within the specific cellular elements of the system. 
 
Whilst evidence for the expression of the NMDA receptor subunits has been 
demonstrated in the ENS of rats (23, 24), the expression of specific AMPA receptor 
subunits on neurochemically defined cell-types of the ENS remain to be revealed. 
Since pharmacological data suggest evidence of their expression within the ENS (25-
28), the aims of this study were to molecularly and functionally characterise the 
AMPA receptor system within the colon of the mouse. 
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Methods and materials 
 
All procedures involving experimental animals were approved by the Animal Welfare 
and Ethics Committee of the University of Portsmouth and were performed under a 
Home Office (HO) project licence, by a HO personal licence holder, and in 
accordance with the Animals (Scientific Procedures) Act 1986 (UK) and associated 
procedures. 
 
Animals and tissue 
Adult C57/BL6 male mice, aged 6-8 weeks, were used throughout the study, apart 
from a subset of experiments for which we used transgenic reporter mice which 
expressed green fluorescent protein under the promotors of either the astroglial 
cytoskeletal protein, glial fibrillary acidic protein (GFP-GFAP) (29), or the transcription 
factor Sox10 (GFP-Sox10) (30). The transgenic animals were generously provided 
by Arthur Butt, the University of Portsmouth.  
 
Preparation of tissue from the CNS and ENS 
Mice were anaesthetised with isoflurane and pentobarbitone (1.25 mg/kg of 
bodyweight; i.p.). The animals were transcardially perfused using a fixative 
containing 1% w/v paraformaldehyde and 15% v/v saturated picric acid in 0.1M 
phosphate buffer (pH 7.4) according to previously described protocols (31). After 
perfusion, the brains and colons were removed and post-fixed in the same fixative 
over night at 4oC. The next day, tissue was washed in 0.1M phosphate buffer until it 
was clear of the fixative. For CNS reactions, 60 μm-thick coronal and sagittal 
sections were produced from the hippocampus and cerebellum, respectively, using a 
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Vibratome. For ENS reactions, whole-mount preparations of the longitudinal muscle-
myenteric plexus and circular muscle-submucosal plexus were obtained from the 
colon, using a dissecting microscope and fine forceps. All sections were stored in 
0.1M phosphate buffer containing 0.05% sodium azide. 
 
Immunohistochemistry and confocal microscopy   
Non-specific binding of secondary antibodies was minimised by incubating the tissue 
in 20% normal horse serum (NHS), diluted in Tris-buffered saline containing 0.3% 
Triton-X100 (TBS-Tx), for 2 hours at room temperature. The tissue was then 
incubated overnight at 4o C with a cocktail of primary antibodies (see Supplementary 
Information (SI) Table 1) diluted in either 20% NHS-TBS-TX for whole-mount 
sections of the colon, or TBS-Tx for brain sections. The following day, the tissue was 
washed three times in TBS-Tx  and incubated in a mixture of appropriate secondary 
antibodies conjugated with either Alexa Fluor 488 (Invitrogen, Eugene, OR), 
indocarbocyanine (Cy3; Jackson ImmunoResearch), and indodicarbocyanine (Cy5; 
Jackson ImmunoResearch) for 2 hours at room temperature. The tissue was washed 
three times with TBS-Tx for 10 minutes and mounted on glass slides in Mowiol 
mounting medium (Polysciences) and cover slipped.  
 
Antibody specificity 
The specificity of all the antisera against the glutamate receptor subunits used in this 
study have been reported upon extensively in other studies concerning the CNS (see 
SI Table 1). Method specificity was also tested by omitting the primary antibodies in 
the incubation sequence. To confirm the absence of cross reactivity between IgGs in 
double and triple immunolabelling experiments, some sections were processed 
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through the same immunohistochemical sequence, except that only an individual 
primary antibody was applied with the full complement of secondary antibodies.  
 
Image acquisition 
Sections were examined with a confocal laser-scanning microscope (LSM710; Zeiss, 
Oberkochen, Germany) using either a Plan Apochromatic 20x DIC oil objective 
(NA0.8) (pixel size 0.42 μm), a Plan Apochromatic 40x DIC oil objective (NA1.3) 
(pixel size 0.29 μm) or a Plan Apochromatic 63x DIC oil objective (NA1.4) (pixel size 
0.13 μm). Z-stacks were used for routine evaluation of the labelling. All images 
presented represent a single optical section. These images were acquired using 
sequential acquisition of the different channels to avoid cross-talk between 
fluorophores, with the pinholes adjusted to one airy unit. Images were processed with 
the software Zen2009 Light Edition (Zeiss, Oberkochen, Germany) and exported into 
Adobe Photoshop. Only brightness and contrast were adjusted for the whole frame, 
and no part of a frame was enhanced or modified in any way.  
 
Reverse transcription-polymerase chain reaction (RT-PCR) 
Small segments of freshly isolated colon and whole brain from three different male 
C57/BL6 mice were obtained and the tissue was rapidly broken down using a pestle 
and mortar. The samples were then subjected to RNA extraction using RNeasy mini 
kit (Qiagen) as per the manufacturer’s protocol. The total concentration and the purity 
of prepared RNA was determined using a NanoDrop spectrophotometer (Thermo 
Scientific). After extraction, the RNA was reverse transcribed into complementary 
DNA (cDNA) using a SuperScript™ First-Strand Synthesis System for RT-PCR kit 
(Invitrogen) in 20 ul reactions. Subsequently, equal amounts of cDNA (2 µl) were 
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used for polymerase chain reaction (PCR) together with GoTaq green master mix 
(Promega), PCR grade water and primers specific for each of the AMPA receptor 
subunits (SI Table 2). All the AMPA receptor subunit-specific PCR primers used in 
this study have been previously published (32). Whole brains of the same animals 
were used as a positive control. Finally, the products of RT-PCR for the transcripts of 
the AMPA receptor subunits in the mouse brain and colon were run on a 2% agarose 
gel and the DNA was visualised by SYBR green staining. 
 
Isometric tension recordings of the effects of AMPA receptor activation on the force 
and frequency of spontaneous contractions of the isolated mouse colon 
This preparation was used to investigate the effect of AMPA receptor activation on 
the force and frequency of spontaneous colonic contractions in vitro, according to our 
previously published protocols (31). Six to eight weeks old male mice were killed by 
cervical dislocation, the distal colon was removed and immediately placed in 
physiological solution containing (in mM): NaCl 140, NaHCO3 11.9, D+ glucose 5.6, 
KCl 2.7, MgCl2.6H2O 1.05, NaH2PO4.2H2O 0.5, CaCl2 1.8, warmed to 32°C. The 
intraluminal contents were removed by gently flushing the colon with the 
physiological solution. Two cm-long segments were mounted in a Harvard organ bath 
(10 ml chamber) filled with the physiological solution (32oC) and bubbled with gas 
containing 95% O2 and 5% CO2. Contractile activity for each colon tissue strip was 
recorded using an isometric force transducer (range 0-25 g) connected to a bridge 
amplifier, which was in turn connected to a dedicated data acquisition system (Power 
Lab 2.20 AD Instruments). The sampling frequency was set to 40 Hz and the 
sensitivity of recording was set to 500 mV. The apparatus was then calibrated using 
a one gram weight in order to express the changes in the amplitude detected by the 
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transducer into grams of force. The tissue was then placed under 1 gram of resting 
tension and allowed to equilibrate for 30 minutes. The AD instrument lab chart 7 
program installed on a PC was used to monitor, record and analyse the spontaneous 
activity. After a stable baseline was established, 10 µM of CPW399, a pan AMPA 
receptors agonist, was added to the bath and the tissue was allowed to reach 
maximum response. Ten minute epochs before and after the drug additions were 
used for quantification of the drug-induced changes in the force and frequency of 
colonic spontaneous contractions. One piece of tissue was used per animal. The 
frequency and amplitude of individual spontaneous contractions was manually 
counted before and after the drug and the average for that animal determined. A 
mean value for the individual averages was obtained for a particular drug. An N value 
thus represents one animal and the data are presented as the mean ± SD. 
 
Statistical analysis 
All data are presented as the arithmetic mean ± SD unless stated otherwise. 
Statistical comparisons were made using Student’s t test with N representing the 
number of animals used. 
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Results 
 
Immunolocalisation of glutamate transporter proteins in the ENS of the mouse colon  
As a prelude to determining the location of specific AMPA receptor subunits within 
the ENS of the mouse colon, we investigated the expression of different classes of 
glutamate transporter proteins in order to assess the glutamatergic regulatory system 
within this region of the mouse ENS. Evaluation of immunoreactivity for the three 
vesicular glutamate transporter (VGLUT) proteins (VGLUT 1-3) revealed VGLUT2 to 
be the predominant subtype expressed within ENS neurons of the mouse colon (Fig. 
1). Indeed, VGLUT2 immunoreactivity presented as varicosities decorating neurons 
of ganglia both within the myenteric (Fig. 1 A) and submucosal (Fig. 1 B) plexuses, 
visualised by immunoreactivity for the acetylcholine synthesising enzyme choline 
acetyltransferase (ChAT). Within the CNS, VGLUT2 is enriched within presynaptic 
terminals and is indicative of synaptic glutamate release sites. If this sub-cellular 
localisation pattern is mirrored in the ENS, then this distribution of VGLUT2 
immunoreactivity suggest widespread synaptic release of glutamate within the 
cellular networks of the ENS of the mouse colon. No specific signal was detectable 
for VGLUT1 and VGLUT3. 
 
In light of the strong association of glutamate transporter immunoreactivity within 
ENS neuronal elements demonstrated above, we then assessed whether, the other 
major cell-type within the ENS, namely enteric glia also exhibit an association with 
the molecular machinery which regulates glutamate levels. We therefore performed 
immunohistochemistry for the glutamate transporter subtype, which at least within the 
CNS, is principally expressed by glia, namely the excitatory amino acid transporter 1 
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(EAAT1), using tissue from reporter mice which express green fluorescent protein 
(GFP) under the promotors of either the scaffolding protein glial fibrillary acid protein 
(GFAP-GFP) (29) or the transcription factor Sox10 (Sox10-GFP) (30). GFAP and 
Sox10 have been shown to be exclusively expressed in enteric glia (33). In tissue 
from GFAP-GFP mice, immunoreactivity for EAAT1 within the ENS of the colon 
presented as individual clusters which decorated the periphery of neuronal profiles, 
identified by immunoreactivity for the calcium binding protein calretinin (Fig. 2 A1). 
Examination of the association between EAAT1 and GFP (Fig. 2 A2) revealed 
extensive areas of co-localisation between these signals suggesting that EAAT1 
signal is predominantly located on glial, rather than neuronal surfaces (Fig. 2 A3). 
This strong association of EAAT1 expression with enteric glia was reproduced in 
tissue from Sox10-GFP mice. Immunoreactivity for EAAT1 was once again enriched 
on the periphery of calretinin-immunopositive cell surfaces (Fig. 2 B1) and appeared 
to co-localise predominantly with Sox10-GFP immunopositive profiles (Fig. 2 B2, 3). 
This distribution pattern of EAAT1 was evident in both myenteric and submucosal 
plexuses. Collectively, these data suggest that enteric glia possess the molecular 
machinery to regulate extracellular glutamate levels within the ENS of the mouse 
colon thereby contributing to the glutamatergic neurotransmission within this region 
of the GIT. 
 
AMPA receptor subunit mRNA expression within the mouse colon  
We then investigated which particular subunits are expressed at the mRNA levels 
within this region of the GIT, using RT-PCR and homogenate of whole mouse colon. 
Homogenates of mouse brain were used as a positive control. RT-PCR revealed 
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mRNA expression within the colon for all AMPA receptor subunits except the GluR2 
subunit (Fig. 3, N = 3 animals).  
 
Confirmation of AMPA receptor subunit immunoreactivity patterns in brain tissue  
Allied to the mRNA analysis above where we used brain as a positive control, we 
performed immunohistochemistry for the AMPA receptor subunits on brain tissue in 
order to confirm that the antibodies and our reaction conditions reproduce previous 
reports within the CNS as well as allowing for the comparison of CNS localisation 
patterns with that of the ENS. In our preliminary investigations, we were not able to 
detect any specific immunoreactive signal within the ENS using the available 
antibodies against the GluR2 and 3 subunits, even though these antibodies exhibited 
specific staining within the CNS. Therefore, we report the immunohistochemical 
staining for only the GluR1 and 4 subunits. 
 
In the cerebellum, labelling for the GluR1 subunit was restricted to the molecular 
layer (Fig. 4 A1, A2), in agreement with previous reports (34), and was clustered on 
Purkinje cell dendritic spines, closely apposed to immunoreactivity of postsynaptic 
density 95 protein (PSD-95), which is an anchoring protein enriched in excitatory 
synapses (Fig. 4 A3). In the forebrain, labelling for the GluR1 subunit was also 
enriched within the hippocampus (Fig. 4 A4, A5), in agreement with previous reports 
(35). Once again, GluR1-immunoreactivity was clustered on dendrites closely 
apposed to PSD-95 immunoreactive clusters (Fig. 4 A6).   
 
The immunoreactivity pattern of the GluR4 subunit closely mirrored that of the GluR1 
subunit and was in accordance with previously published evidence (36), with signal 
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within the cerebellum restricted to the molecular layer (Fig. 4 B1, 2) and closely 
associated with that of PSD-95 (Fig. 4 B3). In agreement with previous evidence 
(36), we did not observe any specific signal for the GluR4 subunit in the 
hippocampus (Fig. 4 B4, B5). Collectively these data indicate that the antibodies, 
which used under our reaction conditions, provide immunoreactivity patterns which 
are consistent with previously published reports. 
  
Immunolocalisation of PSD-95 in the ENS of the mouse colon 
To identify the putative locations of excitatory synapses within the ENS of the mouse 
colon, we used immunoreactivity for the anchoring protein PSD-95, which has been 
shown to be enriched within the postsynaptic compartments of excitatory synapses in 
both the CNS (37) and ENS (38). Immunoreactivity for PSD-95 signal presented as 
individual clusters on somatic and dendritic surfaces of ENS neurons (Fig. 5 A1) 
which were closely apposed to glial processes (Fig. 5 A2, 3).  
 
Immunolocalisation of the AMPA subunits within the ENS of the mouse colon 
Immunoreactivity for the GluR1 subunit was widely distributed on neurons composing 
the ganglia of the myenteric and submucosal plexuses, identified by immunoreactivity 
for nitric oxide synthase (NOS) (Fig. 6A). However, it was noticeable that some 
neurons were devoid of immunoreactivity for GluR1 (Fig. 6 A, arrowheads), whilst 
some NOS-immunoreactive neurons displayed robust GluR1 signal (arrows), 
suggesting a degree of cell specific expression for this subunit. We used a range of 
neurochemical markers and high-resolution imaging to confirm which particular types 
of ENS neurons express the GluR1 subunit. GluR1 immunoreactivity appeared as 
individual clusters on somato-dendritic cells surfaces of calretinin-immunopositive 
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(Fig. 6 B1), ChAT-immunopositive (Fig. 6 B2) and on a sub-population of NOS-
positive (Fig. 6 B3) neurons. However, we did not detect any GluR1 signal 
associated with somatostatin-immunopositive neurons (Fig. 6 B4).  
 
The labelling pattern of the GluR4 subunit mirrored that of the GluR1 subunit, with a 
widespread distribution evident throughout ENS ganglia (Fig. 7 A), although it was 
evident that the intensity of the signal varied across collections of neurons (Fig. 7A, 
arrowheads). Using a range of neurochemical markers, we detected 
immunoreactivity for the GluR4 subunit on the somato-dendritic surfaces of NOS-
expressing neurons (Fig. 7 B1) and ChAT-positive enteric neurons (Fig. 7 B2). Unlike 
the GluR1 subunit, GluR4 subunit was not expressed on calretinin-expressing 
neurons (Fig. 7 B3). We also did not detect specific GluR4 labelling on somatostatin-
immunoreactive enteric neurons (Fig. 7 B4).  
 
A striking observation was the location of GluR4 immunoreactivity on axonal profiles, 
particularly on varicose plexes, identified by immunoreactivity for NOS (Fig. 7 C), 
suggesting the expression of this subunit on both pre- and postsynaptic 
compartments.  
Collectively, these data indicate that the GluR1 and 4 subunits are divergently 
expressed within the cellular networks of the ENS of the mouse colon being targeted 
to not only different sub-populations of ENS neurons but to different sub-cellular 
domains.  
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The effect of AMPA receptor activation on spontaneous colonic contractions  
In order to explore the functional consequences of AMPA receptor activation on one 
aspect of colonic function, namely contractility, we applied the AMPA receptor 
agonist CPW399 to isolated mouse colon segments and measured the changes in 
the force and frequency of spontaneous longitudinal muscle contractions. CPW399 
has been shown to be a potent agonist at GluR1 and GluR2 subunit-containing 
AMPA receptors and exhibits minimal desensitisation of these receptors (39), thus 
allowing for examination of the effects of prolonged AMPA receptor activation. 
CPW399 at bath concentration of 10 µM significantly increased the force of 
spontaneous contractions (mean ± SD; baseline, 0.1 ± 0.05 grams versus CPW399, 
0.18 ± 0.07 grams, N = 4 animals; P = 0.008, paired Student’s t test) (Fig. 8A, B). 
However, CPW399 at this concentration had no significant effect on the frequency of 
spontaneous contractions (mean ± SD; baseline, 0.067 ± 0.003 Hz versus CPW399, 
0.068 ± 0.005 Hz, N = 4 animals; P = 0.565, paired Student’s t test) (Fig. 8C).  
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Discussion 
 
In the current study, we demonstrate that the GluR1 and 4 receptor subunits are 
divergently expressed within the neuronal networks of the ENS of the mouse colon 
and that the activation of AMPA receptors directly influences colonic spontaneous 
contractility. In addition, we provide evidence for the expression of the molecular 
machinery which regulates glutamate levels within this region of the GIT. The 
implication is that the glutamate-AMPA receptor system is an integral component of 
the neural networks which underlies the modulation of colonic function within the 
mouse.  
 
Technical considerations 
Whilst the immunohistochemical expression of various AMPA receptor subunits 
within the CNS has been comprehensively described, relatively less is known about 
the precise cellular localisation patterns in the peripheral nervous system, including 
the ENS of the mouse colon. The specificity of the CNS labelling pattern of the GluR 
antibodies used in this study has been verified in knockout mice (data from 
manufacturer). Unfortunately, the lack of available tissue from such knockout mice 
precludes similar ENS analyses in this study. We therefore performed parallel studies 
in tissue from both the CNS and ENS in order to confirm the consistency of the 
antisera under our reaction conditions. The staining patterns obtained in the mouse 
cerebellum and hippocampus with antibodies against the GluR1 and 4 subunits were 
indistinguishable to those previously reported confirming their specificity (Fig.  4). 
Further evidence of the specificity of the GluR subunit antibodies used is that the 
cellular immunoreactivity patterns within the ENS not only mirrored the CNS 
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phenotype but also fulfilled the expectations for neurotransmitter receptor proteins 
which are predominantly expressed in synaptic junctions. Indeed, the 
immunoreactivity presented as membrane-bound clusters with relatively less signal 
evident in the cytoplasm (Fig. 6, 7). An additional level of evidence for the expression 
of these AMPA subunits within the mouse colon was obtained by confirming their 
expression at the mRNA level (Fig. 3), with the obvious caveat that expression at the 
mRNA level may not necessarily mean expression at the protein level. Allied to our 
mRNA data, we did encounter technical problems in terms of obtaining specific ENS 
immunolabelling with antibodies against the GluR2 and 3 subunits even though these 
antisera reproduced previously reported CNS labelling patterns. Nevertheless, our 
combined data in the CNS and ENS on the localisation of the GluR1 and 4 subunits 
provides novel insights into glutamate receptor expression within this region of the 
mouse colon. 
 
Glutamate receptor expression in the ENS 
The expression of glutamate within the cellular networks of the ENS is well 
documented (12) as well as its evidence as a neurotransmitter in this branch of the 
nervous system (19, 40). Although several studies have demonstrated, at a 
functional level, that application of glutamate has an excitatory impact on enteric 
neurons; there is contradictory evidence with respect to which glutamate receptors 
are involved in mediating these effects. For instance, one study suggests that the 
excitatory effect of glutamate is mediated via metabotropic glutamate receptors and 
not the ionotropic receptors (41), while others show that such effects are mediated 
via ionotropic receptors such as AMPA receptors (12, 22). Furthermore, despite 
functional evidence for the presence of different glutamate receptor subtypes (41), 
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relatively less is known about the distribution of particular receptor subtypes amongst 
the various cell-types which compose the ENS. This is lamentable since the 
elaboration of the rich expression profiles of various glutamate receptor subtypes 
throughout the cell-types and connected pathways of the CNS has been instrumental 
in sketching the landscape of the glutamate system and its contribution to various 
facets of neural function. Therefore, identifying not only the molecular substrates of 
ENS glutamatergic neurotransmission, but also their positioning within connected 
circuitry will inform the future functional exploration of the ENS glutamatergic system 
and its role in GI health and disease.  
 
The majority of evidence for glutamate receptor expression and function within the 
ENS and GIT is related to the metabotropic (mGluR) sub-class. Indeed, 
immunolabelling for different sub-classes of mGluR receptors has been reported to 
be localised to various populations of ENS neurons (42, 43). Less is known about the 
location of ionotropic glutamate receptor subtypes within ENS circuitry, in particular 
the NMDA and AMPA subtype. Expression of the NR1 subunit within the ENS has 
been demonstrated at both the mRNA level (24, 44) and protein levels (12, 45).  In 
contrast, the native location of different AMPA receptor subunits has been reported 
only in the guinea pig small intestine (12). This study reported GluR1-4 subunits to be 
localised within the cytoplasm of ENS neurons.  In contrast, our data, obtained from 
the mouse large intestine revealed that immunoreactivity for the GluR1/4 subunits 
was predominantly localised to somato-dendritic plasma membranes (Figs. 6, 7), the 
site of expression expected from proteins which primarily function in synaptic 
junctions. Furthermore, these somato-dendritic expression patterns of the GluR1/4 
subunits was closely aligned with the molecular machinery which regulates either 
 Seifi                       20 
 
synaptic or extrasynaptic glutamate levels, namely vesicular glutamate transporter 2 
(Fig. 1) or the glial glutamate transporter (Fig. 2) respectively. In agreement with data 
from (12), we confirmed the neurochemical identity of some of the GluR-expressing 
ENS neurons to be immunoreactive for Chat, NOS and calretinin, although not 
somatostatin, which is predominantly expressed within enteric interneurons (46) 
(Figs. 6, 7). Collectively, these data in the mouse colon build on what has been 
previously reported in the small intestine of the guinea pig by providing a high-
resolution image of the complexity of the glutamate-AMPA receptor system within the 
cellular networks of the ENS.  
 
Glutamate receptor activation and GI motility 
In light of the complex expression patterns demonstrated above, we chose to 
examine the possible functional role of such receptors in only one aspect of GI 
function, namely motility, using spontaneous colonic contractions as a surrogate 
marker. The role of glutamate in influencing intestinal contractility has been widely 
reported with evidence indicating a pro-contractile effect (40). Various classes of both 
ionotropic and metabotropic glutamate receptors have been implicated in such 
actions (25, 47). Indeed, in guinea pig, AMPA receptor activation has been shown to 
enhance neurotransmitter release which enhanced peristalsis (26). Our data using 
the mouse colon corroborate a role for AMPA receptors in enhancing GI contractility. 
Intestinal motility or peristalsis arises from the coordinated contraction and relaxation 
of circular and longitudinal smooth muscles (48). Even though we used a preparation 
which detects the spontaneous contractions of only the longitudinal smooth muscles 
of the colon, we were able to demonstrate that the pharmacological activation of all 
AMPA receptor subtypes enhanced the force of spontaneous contractions (Fig. 8). 
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Notably, the frequency of such contractions remained unaltered. The balance of 
neurotransmitter release from acetylcholine (1) and NOS-containing (49) ENS 
neurons is thought to determine the tone of the contraction and relaxation of 
intestinal smooth muscle contractions. A distinct cell-type, namely the interstitial cells 
of Cajal (ICC), is primarily responsible for setting the frequency or rhythm of such 
smooth muscle contractions. Collectively, this rhythmic contraction of varying 
degrees of force by smooth muscles allows for the optimal prolusion of intestinal 
contents. Our study revealed that both cholinergic and NOS-containing neurons 
expressed the GluR1/4 subunits. The simplistic extrapolation would be that activation 
of these subunits would results in the excitation of both cholinergic and NOS-
containing neurons, resulting in opposing actions on smooth muscle contraction. A 
possible explanation could be different levels of GluR 1 and 4 subunits expressed on 
either cholinergic and NOS-immunopositive neurons, resulting in different levels of 
activation when exposed to a pan-AMPA receptor agonist. It is not possible to 
explore this theory using immunohistochemistry since the antibodies against the 
GluR1 and 4 subunits are likely to have inherently different binding affinities. 
Therefore, in order to dissect the respective function of GluR1 or 4 subunit-containing 
AMPA receptors on cholinergic and NOS-containing ENS neurons, it would be 
essential to measure the amplitude of AMPA-mediated excitatory postsynaptic 
currents at the single cell level of such identified neurons. Nevertheless, it was 
notable that we were not able to detect any specific signal for the GluR1/4 subunits 
on ICC (data not shown), which concurs with the lack of an effect of the AMPA 
agonist on the frequency of spontaneous contractions.   
 
 
 Seifi                       22 
 
Glutamate receptors in GI disorders 
The glutamate-receptor system impacts on a range of GI functions such as motility, 
(25, 40, 50) as well as secretory and electrolyte balance (27, 28, 51). However, apart 
from their roles in GI homeostasis, there is growing evidence implicating the 
dysregulation of different glutamate receptors, with the ensuing excitotoxicity (22) 
contributing to various GI disorders such as GI inflammation (52), irritable bowel 
syndrome (IBS) (53), visceral pain (54) and intestinal cancer (55). Whilst most of the 
current evidence implicates NMDA and mGluR receptors subtypes, roles of AMPA 
receptors in such disorders are relatively poorly explored. The current study provides 
the anatomical foundation for exploring potential changes in the AMPA receptor 
system of the ENS of the mouse colon, using various models of GI disorders.  
 
In summary, the study provides a high resolution map of the location of GluR 
subunits within the major cell-types of the ENS of the mouse colon, alongside the 
molecular machinery which regulates glutamate neurotransmission. In addition, we 
provide evidence that the pharmacological activation of such receptors directly 
influences colonic contractility. The data provide a platform for future molecular and 
functional analyses of the glutamate-AMPA receptor system in GI health and 
disease. 
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Figure legends 
 
Figure 1 
Immunolocalisation of the vesicular glutamate 2 transporter (VGLUT2) in the ENS of 
the mouse colon 
(A1 and B1) show immunoreactivity for the choline acetyltransferase (ChAT) 
demonstrating the location of putative cholinergic neurons within ganglia of the 
myenteric and submucosal plexus respectively. (A2 and B2) show immunoreactivity 
for the VGLUT2 within the same fields of view. (A3 and B3) are overlays of (A1, A2) 
and (B1, B2) respectively, showing the widespread association of VGLUT2 
immunoreactive varicosities within the myenteric and submucosal plexus neurons of 
the mouse colon. Note that (A3) is a magnified version of the boxed area in (A1) and 
(A2). Scale bars: (A) 50 µm; (B) 20 µm 
 
Figure 2 
Association of immunoreactivity for the excitatory amino acid transporter 1 (EAAT1) 
with enteric glia of the ENS of the mouse colon 
(A1 and B1) show EAAT1 immunoreactive clusters decorating enteric neurons 
visualised by immunoreactivity for the calcium binding protein and ENS neuronal 
marker, calretinin. (A2 and B2) show the widespread association of the EAAT1 
immunoreactive clusters with enteric glia which in (A2) are identified by the 
expression of green fluorescent protein (GFP) which is driven by the promotor for the 
glial cytoskeletal protein, glial fibrillary acid protein (GFAP), and in (B2) by GFP 
expression which is driven by the promotor for the transcription factor Sox10. (A3 and 
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B3) are overlays of (A1, B1) and (A2, B2) respectively, showing the close association 
between immunoreactivity of EAAT1 with enteric glial profiles. 
Scale bars: 10 µm 
 
Figure 3 
Expression of AMPA receptor subunits in the mouse colon at the mRNA level 
The image is a photomicrograph of a representative electrophoresis gel showing 
mRNA transcripts for the AMPA (GluR) 1-4 subunits using RT-PCR performed on 
homogenates from whole mouse brain and colon.  
Corresponding amplicons of the same size to those obtained from brain samples 
were consistently detected for the GluR1, 3, 4 subunits but not the GluR2 subunit in 
colon samples (N = 3 animals). A negative control, no RT reaction was performed 
with every experiment and brain samples were used as positive control. 
 
Figure 4 
Immunolocalisation of the GluR1 and 4 subunits in the mouse CNS 
(A1) shows immunoreactivity for the calcium-binding protein, calbindin, in a sagittal 
section of the mouse cerebellum. The signal is restricted to the somata and dendrites 
of Purkinje neurons. In the corresponding field of view, immunoreactivity for (A2) the 
GluR1 subunit mirrors that of calbindin and is enriched in the molecular layer. (A3) is 
a high resolution image of the molecular layer showing clustered GluR1 
immunoreactivity (green) closely associated with immunoreactivity for the excitatory 
synaptic marker protein, postsynaptic density 95 (PSD95) (red), on calbindin-
immunopositive dendrites. (A4) shows immunoreactivity for the neuronal cytoskeletal 
protein marker, microtubule associated protein 2 (MAP2), within the mouse 
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neocortex and hippocampus. (A5) in the corresponding field of view, 
immunoreactivity for the GluR1 subunit is restricted to the hippocampus. (A6) is a 
high resolution image taken from stratum radiatum of the mouse hippocampus, 
showing clustered GluR1 immunoreactivity (green) closely associated with 
immunoreactivity for PSD95 (red), on MAP2-immunopositive dendrites. (B1) shows 
immunoreactivity for calbindin, in a sagittal section of the mouse cerebellum. In the 
corresponding field of view, immunoreactivity for (B2) the GluR4 subunit is restricted 
to the molecular layer. (B3) is a high resolution image of the molecular layer showing 
clustered GluR4 immunoreactivity (green) closely associated with immunoreactivity 
for PSD95 (red), on calbindin-immunopositive dendrites. (B4) shows 
immunoreactivity for MAP2, within the mouse neocortex and hippocampus. (B5) in 
the corresponding field of view, no specific signal the GluR4 subunit was detected. 
Scale bars: (A, B, 1-2, 4-5) 500 µm; (A 3, 6, B 3) 3 µm 
 
Figure 5 
Immunolocalisation of the postsynaptic marker protein postsynaptic density 95 
(PSD95) in the ENS of the mouse colon 
(A1) shows immunoreactivity for (PSD95) (red) is targeted to the somato-dendritic 
regions of enteric neurons, identified by immunoreactivity for nitric oxide synthase 
(NOS) (blue). (A2) shows that in the corresponding field, PSD95 immunoreactive 
clusters are also closely associated with putative enteric glial profiles, identified by 
the expression of GFP driven by the transcription factor Sox10. (A3) is an overlay of 
A1 and A2.  Scale bar: 10 µm 
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Figure 6 
Immunolocalisation of the GluR1 subunit in the ENS of the mouse colon  
(A1) is an overview of a region of the myenteric plexus showing numerous ganglia, 
identified by immunoreactivity for NOS. (A2) shows that in the corresponding field of 
view, immunoreactivity for the GluR1 subunit is widely distributed across ganglia. 
However, it is noticeable that some NOS immunoreactive neurons appear to be 
devoid of GluR1 immunoreactivity (arrowheads) whilst GLUR1 signal is evident on 
putative neurons which are devoid of NOS immunoreactivity (arrows). (A3) is an 
overlay of (A1) and (A2). GluR1 subunit immunopositive puncta (red) were detectable 
on the somato-dendritic surfaces of (B1) calretinin-immunopositive, (B2) ChAT-
immunopositive, and (B3) a sub-population of NOS-immunopositive but not the (B4) 
somatostatin-immunopositive enteric neurons. Scale bars: (A) 50 µm; (B) 10 µm 
 
Figure 7 
Immunolocalisation of the GluR4 subunit in the ENS of the mouse colon  
(A1) is an overview of a region of the myenteric plexus showing numerous ganglia, 
identified by immunoreactivity for NOS. (A2) shows that in the corresponding field of 
view, immunoreactivity for the GluR4 subunit is widely distributed across ganglia. 
However, it is noticeable that there are gradients for GluR4 immunoreactivity within 
ganglia (arrowheads). (A3) is an overlay of (A1) and (A2). GluR4 immunoreactive 
clusters were located on the somato-dendritic surfaces of (B1) NOS-immunopositive 
and (B2) ChAT-immunopositive enteric neurons. However, no specific 
immunoreactivity for GluR4 subunit (red) was detected on either (B3) calretinin-
immunopositive or (B4) somatostatin-immunopositive enteric neurons. (C1) shows 
ENS axonal profiles, identified by NOS-immunoreactivity. (C2) in the same field of 
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view, GluR4 immunoreactivity closely follows the pattern of NOS labelling. (C3) an 
overlay of the boxed areas in (C1) and (C2) showing the extensive degree of co-
localisation of GluR4 immunoreactivity with that of NOS, particularly within the axonal 
varicosities (arrowheads). 
Scale bars: (A) 50 µm; (B) 10 µm; (C) 20 µm  
 
Figure 8  
The pharmacological effect of activating AMPA receptors on spontaneous colonic 
contractions 
(A) shows a representative trace demonstrating the effect of the AMPA receptor 
agonist CPW399 on the spontaneous longitudinal smooth muscle contractions in an 
isolated segment of the mouse colon. Note the significant increase in the size of 
spontaneous contractions after administration of CPW399. Quantification of the effect 
of CPW399 10 µM on (B) the force and (C) the frequency of spontaneous colonic 
contractions. Bars represent means and the lines represent the SD. N = 4 animals, * 
P< 0.05. Scale bars: (A) vertical 0.25 grams, horizontal 2.5 minutes. 
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Supplementary Tables 
Supplementary Table 1 
Details of primary antibodies used in the study 
Antibody Host Dilution Source References 
Calretinin Rabbit 1:1000 Swant (7699/3H) 
(56), (57) 
ChAT Goat 1:100 Millipore (AB144P) 
(58), (59) 
c-Kit Rat 1:250 eBioscience (14-1172) 
(60), (61) 
CRF Guinea-pig 1:1000 Peninsula Labs (T-5007) 
(62), (63) 
  
GluR1 Guinea-pig 1:500 
Frontier institute 
(GluA1-GP-Af380) 
(64), (65) 
GluR4 Guinea-pig 1:500 
Frontier institute 
(GluA4N-GP-Af640) 
(66) 
NOS Sheep 1:1000 Millipore (AB1529) 
(67), (68)  
Somatostatin Rat 1:500 Millipore (MAB354) 
(69), (70) 
 
VGLUT2 Rabbit 1:1000 Synaptic systems (135403) 
(71), (72) 
EAAT1 Rabbit 1:1000 Abcam (ab416) 
(73) 
PSD 95 Rabbit 1:1000 Invitrogen (51-6900) 
(74) 
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Supplementary Table 2 
Table of RT-PCR primer sequences 
Gene Primer sequence 
RT-PCR Product 
length (bp) 
Reference 
GluR1 
GGA CGA GAT CAG ACA ACC AG 
TCG TAC CAC CAT TTG TTT TTC A 
 
792 (32) 
GluR2 
GAG AAA CAC AAA GTA GT 
TCG TAC CAC CAT TTG TTT TTC A 
 
792 (32) 
GluR3 
TGA CCC ACA AAG CCC TCC TG 
TCG TAC CAC CAT TTG TTT TTC A 
 
798 (32) 
GluR4 
GAA GGA CCC AGT GAC CAG C 
TCG TAC CAC CAT TTG TTT TTC A  
792 (32) 
 
 
 
 
 
 
